Neuropsychiatric and metabolic aspects of dopaminergic therapy: perspectives from an endocrinologist and a psychiatrist

The dopaminergic treatment represents the primary treatment in prolactinomas, which are the most common pituitary adenomas and account for about 40% of all pituitary tumours with an annual incidence of six to ten cases per million population. The dopaminergic treatment includes ergot and non-ergot d...

Descripción completa

Detalles Bibliográficos
Autores principales: Athanasoulia-Kaspar, Anastasia P, Popp, Kathrin H, Stalla, Gunter Karl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825922/
https://www.ncbi.nlm.nih.gov/pubmed/29378769
http://dx.doi.org/10.1530/EC-18-0030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825922/
https://www.ncbi.nlm.nih.gov/pubmed/29378769
http://dx.doi.org/10.1530/EC-18-0030

Ejemplares similares